Key result
This review discusses the historical development, effectiveness, and patient selection for left atrial appendage occlusion devices as an alternative to oral anticoagulation for stroke prevention in AF.
Why the study?
Do left atrial appendage occlusion devices prevent cardioembolic stroke in patients with atrial fibrillation compared to warfarin and novel oral anticoagulants?
Do left atrial appendage occlusion devices prevent cardioembolic stroke in patients with atrial fibrillation compared to warfarin and novel oral anticoagulants?
This review discusses the historical development, effectiveness, and patient selection for left atrial appendage occlusion devices as an alternative to oral anticoagulation for stroke prevention in atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
LAAO selection in AF should remain individualized; review leaves open comparative long-term efficacy versus contemporary NOACs.
Le et al. (2015) conducted a review in Atrial fibrillation. Left atrial appendage occlusion devices vs. Warfarin and novel oral anticoagulation therapy was evaluated on Cardioembolic stroke. This review discusses the historical development, effectiveness, and patient selection for left atrial appendage occlusion devices as an alternative to oral anticoagulation for stroke prevention in AF.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: